DrugPatentWatch Database Preview
Details for Patent: 8,367,102
Email this page to a colleague
See Plans and PricingWhich drugs does patent 8,367,102 protect, and when does it expire?
Patent 8,367,102 protects ABSORICA and is included in one NDA.
This patent has twelve patent family members in nine countries.
Summary for Patent: 8,367,102
| Title: | Pharmaceutical semi-solid composition of isotretinoin |
| Abstract: | An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e. having an HLB value superior or equal to 10), the other being an oily vehicle. |
| Inventor(s): | Vanderbist; Francis (Beersel, BE), Servais; Cecile (Malonne, BE), Baudier; Phillippe (Uccle, BE) |
| Assignee: | Galephar Pharmaceutical Research, Inc. (Juncos, PR) |
| Application Number: | 11/892,363 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,367,102 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Dosage form; |
Drugs Protected by US Patent 8,367,102
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-001 | May 25, 2012 | BX | RX | Yes | No | Start Trial | Start Trial | TREATMENT OF A SKIN DISORDER | Start Trial | |||
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-002 | May 25, 2012 | BX | RX | Yes | No | Start Trial | Start Trial | TREATMENT OF A SKIN DISORDER | Start Trial | |||
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-005 | Aug 15, 2014 | RX | Yes | No | Start Trial | Start Trial | TREATMENT OF A SKIN DISORDER | Start Trial | ||||
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-003 | May 25, 2012 | BX | RX | Yes | No | Start Trial | Start Trial | TREATMENT OF A SKIN DISORDER | Start Trial | |||
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-006 | Aug 15, 2014 | RX | Yes | No | Start Trial | Start Trial | TREATMENT OF A SKIN DISORDER | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,367,102
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Belgium | 2000/0111 | Sep 22, 2000 |
International Family Members for US Patent 8,367,102
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 270544 | Start Trial | |||
| Australia | 8943801 | Start Trial | |||
| Brazil | 102013032172 | Start Trial | |||
| Canada | 2423170 | Start Trial | |||
| Canada | 2836228 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
